These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3287144)

  • 1. [Preventive long-term intravenous immunoglobulin infusion in children with acute lymphatic leukemia. I. Anticomplementary activity of gamma globulin preparations is a function of the preparation and IgG concentration prior to infusions].
    Nürnberger W; Willers R; Körholz D; Göbel U; Wahn V
    Monatsschr Kinderheilkd; 1988 Mar; 136(3):116-20. PubMed ID: 3287144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preventive long-term intravenous immunoglobulin infusion in children with acute lymphatic leukemia. II. Zymosan opsonization is decreased and is not increased by IgG infusions].
    Nürnberger W; Willers R; Schroten H; Bünning G; Göbel U; Wahn V
    Monatsschr Kinderheilkd; 1988 Apr; 136(4):181-5. PubMed ID: 3164442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The anticomplementary activity of 2 intravenous gamma globulin preparations in children with acute lymphatic leukemia].
    Wahn V; von Kries R; Ebell W; Jürgens H; Göbel U
    Immun Infekt; 1984 Apr; 12(2):115-8. PubMed ID: 6442915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anaphylactic shock reaction following intravenous administration of 7S immunoglobulin in patients with hypogammaglobulinemia, especially in children with acute lymphoblastic leukemia (ALL)].
    Manzke H; Seifert J
    Klin Padiatr; 1987; 199(4):274-8. PubMed ID: 3116320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement C3 deposition onto bacteria by neonatal serum is not enhanced after the infusion of intravenous immunoglobulin.
    Lassiter HA; Speranza MJ; Hall RT; Meade V; Christensen RD; Parker CJ
    J Perinatol; 1990 Mar; 10(1):27-31. PubMed ID: 2107285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tolerability and pharmacokinetics of an intravenous immunoglobulin preparation in immunologically normal subjects and tolerability in patients with hypogammaglobulinemia resulting from chronic lymphatic leukemia].
    Huser HJ; Schwander D; Wegmann A; Chariatte N; Fässler MA
    Schweiz Med Wochenschr; 1986 Feb; 116(5):151-6. PubMed ID: 3515530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Blood platelet function following gamma globulin infusions in children with acute lymphatic leukemia during the remission-maintaining long-term therapy].
    von Kries R; Jürgens H; Wahn V; Göbel U
    Immun Infekt; 1984 Apr; 12(2):119-22. PubMed ID: 6598455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective study of immunoglobulin treatment as part of a multi-factorial therapy in children with acute lymphatic leukemia.
    Kornhuber B
    Arzneimittelforschung; 1981; 31(11):1930-1. PubMed ID: 6797446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prophylaxis and therapy with gamma globulin. General characterization and clinical use of gamma globulin preparations].
    Barandun S; Skvaril F; Morell A
    Schweiz Med Wochenschr; 1976 Apr; 106(16):533-42. PubMed ID: 62393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of low m.w., C3-bearing immunoglobulin in human serum.
    Jacobs RJ; Reichlin M
    J Immunol; 1983 Jun; 130(6):2775-81. PubMed ID: 6602181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of the intracellular killing of Staphylococcus aureus by monocytes: regulation by immunoglobulin G and complement components C3/C3b and B/Bb.
    Leijh PC; van den Barselaar MT; Daha MR; van Furth R
    J Immunol; 1982 Jul; 129(1):332-7. PubMed ID: 6979568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous pulse cyclophosphamide--a new regime for steroid resistant focal segmental glomerulosclerosis.
    Gulati S; Kher V
    Indian Pediatr; 2000 Feb; 37(2):141-8. PubMed ID: 10745408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease.
    Mori M; Imagawa T; Yasui K; Kanaya A; Yokota S
    J Pediatr; 2000 Aug; 137(2):177-80. PubMed ID: 10931408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The function of the immune system after the treatment of pediatric malignant diseases].
    Gadó J; Schlick B; Bárány O; Németh J; Müller J; Csóka M; Constantin T; Vonnák E; Böcskei R; Hauser P; Kovács G
    Orv Hetil; 2006 Sep; 147(36):1731-8. PubMed ID: 17087017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
    Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ
    J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of persistent IgA/IgG circulating immune complexes associated with activation of the complement system in serum of a patient with common variable immune deficiency: anaphylactic reactions to intravenous gammaglobulin.
    Wahn V; Good RA; Gupta S; Pahwa S; Day NK
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():49-58. PubMed ID: 6203331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement and IgG subclasses in agammaglobulinemic patients.
    Grumach AS; Kirschfink M
    Exp Clin Immunogenet; 1995; 12(1):10-5. PubMed ID: 7710760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous usage of gammaglobulin: humoral immunodeficiency, immune thrombocytopenic purpura, and newer indications.
    Bussel JB; Cunningham-Rundles C
    Cancer Invest; 1985; 3(4):361-6. PubMed ID: 4040795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intravenous immunoglobulin on E. coli opsonization in multiple myeloma.
    Hertler AA; Ross SC
    J Clin Lab Immunol; 1986 Dec; 21(4):177-81. PubMed ID: 3550092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.